Literature DB >> 26240252

Private payers disagree with Medicare over medical device coverage about half the time.

James D Chambers1, Matthew Chenoweth2, Teja Thorat3, Peter J Neumann4.   

Abstract

There are multiple payers in the US health care system, each making its own coverage determinations for medical technologies. For each of the forty-seven medical devices considered in national coverage determinations (NCDs) of the Centers for Medicare and Medicaid Services (CMS) issued between February 1999 and August 2013, we compared CMS's coverage policy with the policies issued by the largest sixteen private payers that made their decisions publicly available. Overall, we found that NCDs were equivalent to the corresponding private payer policies roughly half of the time, more restrictive approximately a quarter of the time, and less restrictive about a quarter of the time. Our findings indicate that patients may have variable access to medical technology across Medicare and private plans. They also suggest that private plans do not necessarily follow CMS's lead in making coverage decisions. Project HOPE—The People-to-People Health Foundation, Inc.

Entities:  

Keywords:  Access To Care; Medical technology; Medicare

Mesh:

Year:  2015        PMID: 26240252     DOI: 10.1377/hlthaff.2015.0133

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  7 in total

1.  In the Shadow of a Giant: Medicare's Influence on Private Physician Payments.

Authors:  Jeffrey Clemens; Joshua D Gottlieb
Journal:  J Polit Econ       Date:  2016-12-16

2.  Insights From a Temporal Assessment of Increases in US Private Payer Coverage of Tumor Sequencing From 2015 to 2019.

Authors:  Julia R Trosman; Michael P Douglas; Su-Ying Liang; Christine B Weldon; Allison W Kurian; Robin K Kelley; Kathryn A Phillips
Journal:  Value Health       Date:  2020-03-19       Impact factor: 5.725

3.  New Medicare Coverage Policy for Next-Generation Tumor Sequencing: A Key Shift in Coverage Criteria With Broad Implications Beyond Medicare.

Authors:  K A Phillips; J R Trosman; C B Weldon; M P Douglas
Journal:  JCO Precis Oncol       Date:  2018-11-08

4.  Insurance coverage for genomic tests.

Authors:  Kathryn A Phillips; Julia R Trosman; Patricia A Deverka; Bruce Quinn; Sean Tunis; Peter J Neumann; James D Chambers; Louis P Garrison; Michael P Douglas; Christine B Weldon
Journal:  Science       Date:  2018-04-19       Impact factor: 47.728

5.  Coverage Denials: Government And Private Insurer Policies For Medical Necessity In Medicare.

Authors:  Aaron L Schwartz; Yujun Chen; Chris L Jagmin; Dorothea J Verbrugge; Troyen A Brennan; Peter W Groeneveld; Joseph P Newhouse
Journal:  Health Aff (Millwood)       Date:  2022-01       Impact factor: 9.048

Review 6.  Germany's digital health reforms in the COVID-19 era: lessons and opportunities for other countries.

Authors:  Sara Gerke; Ariel D Stern; Timo Minssen
Journal:  NPJ Digit Med       Date:  2020-07-10

7.  Association Between Medicare's National Coverage Determination and Utilization of Next-Generation Sequencing.

Authors:  Daniel M Sheinson; William B Wong; Carlos Flores; Sarika Ogale; Cary P Gross
Journal:  JCO Oncol Pract       Date:  2021-05-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.